Posts Tagged ‘Allergan Inc. (NYSE:AGN)’

Hedge Fund Highlights: Carl Icahn, John Paulson & Sprott Asset Management

ICAHN CAPITAL Carl Icahn
Icahn and Ackman Publicly End Feud With an Embrace (New York Times) A dispute between two billionaire investors, Carl C. Icahn and William A. Ackman......(read more)

Hedge Fund Highlights: Ken Griffin, Paul Tudor Jones & Bill Ackman

CITADEL INVESTMENT GROUP
Citadel’s Griffin Defends HFT (FINalternatives) Citadel Investment Group founder Kenneth Griffin yesterday urged Congress not to ban high-frequency......(read more)

Hedge Fund Highlights: Steven Cohen, George Soros & Bill Ackman

Steven Cohen
SEC Gets Subpoena In Steve Cohen Divorce Suit (Law360) Patricia Cohen, the ex-wife of SAC Capital Advisors LP founder Steven Cohen, has subpoenaed the......(read more)

Hedge Fund Highlights: John Paulson, Bill Miller & Bridgewater Associates

best gold ETF
Paulson’s Credit Opportunities fund up 6.6 percent ytd to end-May: source (Reuters) Hedge fund manager John Paulson‘s credit opportunities......(read more)

Hedge Fund Highlights: Bill Ackman, Philip Falcone & Paul Singer

Can hedge funds beat the market
Allergan Poison Pill Won’t Be Triggered by Pershing Call (Bloomberg) Allergan, Inc. (NYSE:AGN) agreed with Pershing Square Capital Management LP that......(read more)

Hedge Fund Highlights: Warren Buffett, John Paulson & Bain Capital

Warren Buffett
Warren Buffett’s BNSF and Canadian Pacific Railway gets U.S. deadline to solve grain backlog (Financial Post) Warren Buffett’s BNSF Railway Co. and......(read more)

Hedge Fund Highlights: Jeffrey Ubben, Paul Singer & Carl Icahn

VALUEACT CAPITAL
Success of ValueAct Hedge Fund Has Dented Its Maneuverability (Wall Street Journal) Activist investor ValueAct Capital Management has long flown under......(read more)

Hedge Fund Highlights: Carl Icahn, Paul Singer & Philip Falcone

Carl Icahn as viking
U.S. would face hurdles bringing case against Icahn, Mickelson: lawyers (Reuters) Questions about how to apply securities law to activist investors could......(read more)

Hedge Fund Highlights: Tom Steyer, Michael Platt & John Paulson

FARALLON CAPITAL
From black to green: U.S. billionaire’s ‘Road to Damascus’ (Reuters) Billionaire Tom Steyer has rapidly become one of America’......(read more)

Hedge Fund News: Steven Cohen, John Paulson & Dan Loeb

SAC CAPITAL ADVISORS
Hedge fund big furious that his $98M penthouse isn’t selling (Page Six) Embattled hedge fund titan Steven A. Cohen is freaking out that his Manhattan......(read more)

Hedge Fund News: David Einhorn, Barry Rosenstein & George Soros

Greenlight Capital
Greenlight Asked S.E.C. for Delay on Disclosure of Micron Stake (New York Times) David Einhorn, the billionaire hedge fund manager whose stock picks......(read more)

Cramer Tracker: General Motors Company (GM), BP plc (ADR) (BP), Allergan, Inc. (AGN) Among His Latest Bulls

is autozone a good stock to buy?
Editor’s note: Related tickers: General Motors Company (NYSE:GM), BP plc (ADR) (NYSE:BP), Allergan, Inc. (NYSE:AGN), Anadarko Petroleum Corporation......(read more)

Regeneron Pharmaceuticals Inc (REGN), iShares Russell 2000 Index (ETF) (IWM), Brightcove Inc (BCOV): Some Trendy Stocks On Wednesday

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
Editor’s note: Related tickers: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), iShares Russell 2000 Index (ETF) (NYSEARCA:IWM), Brightcove Inc (NASDAQ......(read more)

Allergan, Inc. (NYSE:AGN): Hedge Funds and Insiders Are Bearish, What Should You Do?

Allergan, Inc. (NYSE:AGN)
Is Allergan, Inc. (NYSE:AGN) a bargain? Money managers are selling. The number of bullish hedge fund bets were cut by 5 in recent months. In the eyes......(read more)
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!